e.g. mhealth
Search Results (1 to 10 of 13 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 7 Journal of Medical Internet Research
- 4 JMIR mHealth and uHealth
- 1 JMIR Diabetes
- 1 JMIR Human Factors
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
For this purpose, the names of all apps listed in the Di GA directory in combination with cost-effectiveness terms were entered into Google Scholar.
The database search strategies consisted of search terms related to the intervention and study type. The search was divided into 2 blocks: The first block contained synonyms and generic terms for Di HA. The second block contained terms for health economic study types.
J Med Internet Res 2025;27:e68349
Download Citation: END BibTex RIS
Self-Determined Health App Evaluation Questionnaire Development: Mixed Methods Study
Reference 27: Digital health(https://www.bfarm.de/DE/Medizinprodukte/Aufgaben/DiGA-und-DiPA/DiGA/_node.htmldiga
JMIR Hum Factors 2025;12:e63739
Download Citation: END BibTex RIS
Using either the Di GA prescription date or the receipt of the self-application at TK, a tailored preobservation and follow-up period were determined for each patient. Each patient-individual quarter was defined by 90 days, the duration of the Di GA prescription. The preobservation comprised 8 quarters before the Di GA prescription, while the follow-up ideally encompassed eight quarters, with a minimum of 2. The analysis included people who died during the follow-up.
JMIR Mhealth Uhealth 2025;13:e63935
Download Citation: END BibTex RIS
Vitadio is a Di GA dedicated to patients with type 2 diabetes intended to foster positive lifestyle changes and to support patients in effective self-management. This study aimed to provide evidence of the positive health care effects of Vitadio in individuals with T2 DM. A 6-month, 2-arm, multicenter, randomized-controlled trial was conducted to assess whether using Vitadio is associated with a greater reduction of glycated hemoglobin (Hb A1c) in patients with T2 DM as compared to standard care.
J Med Internet Res 2025;27:e68648
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Digital health application (Di GA) manufacturers with patient-relevant structural and procedural improvement (p SVV; Di GA with p SVV): This category includes decision makers from manufacturers of Di GAs that are listed in the Di GA directory and have implemented p SVV as a positive health care effect.
Di GA manufacturers without p SVV (Di GA without p SVV): This category comprises manufacturers who are listed in the Di GA directory but have not used p SVV as a positive health care effect.
J Med Internet Res 2025;27:e66356
Download Citation: END BibTex RIS
To prove the positive care effect, each Di GA requires conducting a clinical trial within Germany. In addition, a preliminary study demonstrating the Di GA’s basic features is required before preliminary listing as well.
After almost 4 years into the implementation of the Di GA framework, we seek to investigate the evolving landscape of the Di GA market.
J Med Internet Res 2024;26:e59013
Download Citation: END BibTex RIS
A more extensive certification program is the “Fast-Track Process for Digital Health Applications (Di GA)” established in Germany. In this process, in addition to the European conformity certification as proof of “safety” and “suitability,” other requirements, such as “data protection,” “information security,” “interoperability,” and “user-friendliness” are reviewed [6].
J Med Internet Res 2024;26:e49982
Download Citation: END BibTex RIS
Reference 8: Das Fast-Track-Verfahren für digitale Gesundheitsanwendungen (DiGA) nach § 139e SGB V(httpsdiga
JMIR Mhealth Uhealth 2024;12:e50616
Download Citation: END BibTex RIS
Because of the special role of the doctor as a gatekeeper, the doctor is the first to decide whether the patient is suitable for a Di GA. First, the familiar steps such as the patient’s trust in the doctor and the treating doctor’s determination of the patient’s medical condition represent the keystone of the process. Following these steps, when prescribing a Di GA, the next steps are the doctor’s consent to prescribe a Di GA under certain conditions and the assessment of the patient’s ability to use a Di GA.
JMIR Mhealth Uhealth 2024;12:e48345
Download Citation: END BibTex RIS